期刊文献+

HPLC法测定盐酸莫西沙星中R-异构体含量 被引量:5

HPLC assay of R-isomer in moxifloxacin hydrochloride
原文传递
导出
摘要 目的:建立HPLC法对盐酸莫西沙星S-和R-异构体进行拆分并测定其中R-异构体含量。方法:采用AD-H手性柱(DAICEL CHIRALPAK,250 mm×4.6 mm,5μm),流动相为正己烷-异丙醇-二乙胺-乙酸(85∶15∶0.2∶0.1),流速1.0 mL.min-1,柱温35℃,检测波长293 nm;进样量10μL。结果:盐酸莫西沙星异构体之间的分离度为3.4,R-异构体的线性范围为0.54~5.40μg.mL-1(r=0.9995),检测限为1.1 ng,平均回收率(n=9)为99.2%。结论:该方法操作简便,结果准确,可用于盐酸莫西沙星中R-异构体含量测定。 Objective: To establish an HPLC method for enantioseparation of S - and R - moxifloxacin hydrochloride and assay of the R - isomer. Methods: The separation was performed on an AD - H chiral column ( DAICEL CHIRALPAK, 250 mm ×4. 6 mm, 5 μm). The mobile phase was n-hexane -iso-propylalcohol -diethylamine -acetic acid(85: 15:0. 2:0. 1) at the flow rate of 1.0 mL· min^-1 ; The column temperature was 35 ℃, and the detection wavelength was set at 293 nm; The injection volume was 10 μL. Results: The resolution of the isomer was 3.4, the linear range of the R - isomer was 0. 54 - 5.40 μg · mL^- 1 ( r = 0. 9995 ) , the detection limit was 1.1 ng and the average recovery( n =9) was 99.2%. Conclusion: The method is simple and accurate, and can be used for assay of R - isomer in moxifloxacin hydrochloride.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第1期92-94,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 高效液相色谱 手性柱 盐酸莫西沙星 异构体拆分 杂质分离 生产过程监测 HPLC chiral column moxifloxacin hydrochloride isomer resolution impurity separation production process monitoring
  • 相关文献

参考文献8

  • 1江超,周宜遂.莫西沙星合成路线图解[J].中国医药工业杂志,2009,40(5):393-396. 被引量:7
  • 2张志伟,李金伟,董根山.盐酸莫西沙星泡腾片的制备及质量控制[J].中国药房,2007,18(19):1486-1487. 被引量:6
  • 3USP 32 - NF 27. 2009. Suppl(2) :4264.
  • 4Cruz LA, Hall R. Enantiomeric purity assay of moxifloxacin hydro- chloride by capillary electrophoresis. J Pharm Biomed Anal, 2005,38 (1):8.
  • 5Ravikumar M, Varma MS, Raju TS, et al. Enantiomeric separation of moxifloxacin and its ( R, R ) - isomer by ligand - exchange chiral chromatography. Chromatographia, 2009,69 ( 1/2 ) : 85.
  • 6CHEN Ying (陈英). Suggestion on the system suitability test of HPLC in related substances(对HPLC法有关物质系统适用性建立的体会和建议) . Drug Stand China(中国药品标准) ,2010,11 (5) :323.
  • 7谢沐风.如何建立高效液相色谱法测定有关物质的方法[J].中国医药工业杂志,2007,38(1):45-48. 被引量:63
  • 8EP 6.0.2007.2451.

二级参考文献24

  • 1谢沐风.药物溶液稳定性试验的验证方法与重要性[J].药物分析杂志,2005,25(1):107-109. 被引量:28
  • 2朱仁发,王效山.巴洛沙星的合成[J].中国新药杂志,2005,14(9):1162-1164. 被引量:3
  • 3蒋丽娟,蔡冬梅,王涤非,王莉.莫西沙星治疗老年慢性阻塞性肺疾病急性下呼吸道感染临床评价[J].中国抗感染化疗杂志,2005,5(5):291-293. 被引量:17
  • 4李金伟,曹玮.盐酸莫西沙星凝胶的制备及质量控制[J].中国药房,2005,16(24):1873-1874. 被引量:15
  • 5Petersen U, Krebs A, Schenke T, et al. Quinolone- and naphthyridone-carboxylic acid derivative: JP, 2003048890 [P]. 2003-02-21. (CA2001, 135: 61093)
  • 6Takemura M, Kimura Y, Matlsuhashi N. Bicyclic amine derivatives: EP, 603887 [P]. 1994-06-29. (CA 1994, 122: 81351)
  • 7Dreisbach C. Method for racemic biochemical resolution of cis- and trans-pyrrolopiperidine: WO, 9909200 [P]. 1999-02-25. (CA 1999, 130: 156362)
  • 8Kim W J, Park TH, Pearson N, et al. Novel quinolone derivatives and processes for preparing the same: WO, 9415938 [P]. 1994-07-21. (CA 1994, 121: 205332)
  • 9Wang ZQ, Feng SS, Cheng YZ. A novel and economical process for preparing (S,S)-2,8-diazabicyclo[4.3.0]nonane and its enantiomer: WO, 2008085480 [P]. 2007-07-17.
  • 10Klemm L, Johnson W, White D. Thieno (3,4-b)pyridine and thieno (3,4-c) pyridine: US, 3709894 [P]. 1973-01-09.

共引文献73

同被引文献28

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部